However, in our study, both KIT and PDGFRA expression were associated with aggressive tumour characteristics, such as high tumour grade, high proliferation index and poor patient outcome, suggesting them a role in the pathophysiology of at least a subset of serous ovarian carcinomas. The gene discussed is KIT; the disease is neoplasm.